Agenus to participate in leerink partners global biopharma conference

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that dr. garo armen, chairman and ceo, will participate in a fireside chat and investor one-on-ones at the upcoming leerink global biopharma conference on march 11th - 13th in miami beach, florida. the fireside chat will take place at 2:30 p.m. et on march 11th. a live webcast and replay of the fireside chat will be.
AGEN Ratings Summary
AGEN Quant Ranking